Glyphic Biotechnologies, Inc.
Biotechnology company · New York, United States
Glyphic Biotechnologies, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2021. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1.6 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $33 million sold in a notice filed in 2024.
Glyphic Biotechnologies at a glance
What does Glyphic Biotechnologies do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $1.6 million in total (2022 to 2023). NIH funding came from the National Institute of General Medical Sciences, National Human Genome Research Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $33.2 million sold (2024).
Frequently asked questions about Glyphic Biotechnologies
Where is Glyphic Biotechnologies headquartered?
Glyphic Biotechnologies, Inc. is headquartered in New York, United States.
What does Glyphic Biotechnologies do?
Glyphic Biotechnologies, Inc. is a biotechnology company.
When was Glyphic Biotechnologies founded?
The earliest incorporation on record for Glyphic Biotechnologies, Inc. is in 2021, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences